This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of 4567603195 ! SYNOJOYNT 1% SODIUM HYALURONATE, a medical device product, with a ceiling value of $17,130.96 and a performance period ending on March 20, 2025. The contract is a fixed-price with economic price adjustment, and it is not set-aside.
Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida, and it is a registered vendor in the System for Award Management (SAM). The company specializes in developing, manufacturing, and supplying advanced orthopedic products, surgical implants, instruments, and biologics for medical professionals and healthcare systems, including the Department of Veterans Affairs (VA) and the Department of Defense (DoD).
This contract is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as SPE2DE24D0020, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders, covering a comprehensive range of orthopedic products, including surgical implants, arthroscopic instruments, joint replacement technologies, and specialized surgical instrument systems.
Generated 6/16/25, 10:45 AM